Catalogo dei prodotti della ricerca

TRUGLIA, SIMONA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.495
EU - Europa 850
AS - Asia 383
AF - Africa 30
SA - Sud America 20
OC - Oceania 3
Totale 3.781
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.469
IT - Italia 407
SG - Singapore 157
SE - Svezia 146
IN - India 125
CN - Cina 83
FI - Finlandia 70
GB - Regno Unito 34
DE - Germania 32
AT - Austria 28
BG - Bulgaria 27
TG - Togo 24
CA - Canada 20
FR - Francia 20
IE - Irlanda 18
AR - Argentina 13
UA - Ucraina 13
PL - Polonia 7
CH - Svizzera 6
RO - Romania 6
BE - Belgio 5
MK - Macedonia 5
BR - Brasile 4
HU - Ungheria 4
MA - Marocco 4
MX - Messico 4
NL - Olanda 4
AU - Australia 3
ES - Italia 3
HR - Croazia 3
PH - Filippine 3
TR - Turchia 3
AL - Albania 2
GR - Grecia 2
JP - Giappone 2
KZ - Kazakistan 2
RS - Serbia 2
TH - Thailandia 2
AE - Emirati Arabi Uniti 1
AZ - Azerbaigian 1
BN - Brunei Darussalam 1
BO - Bolivia 1
CL - Cile 1
CO - Colombia 1
DK - Danimarca 1
EE - Estonia 1
GH - Ghana 1
ID - Indonesia 1
IL - Israele 1
JM - Giamaica 1
PA - Panama 1
PT - Portogallo 1
RU - Federazione Russa 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
TM - Turkmenistan 1
ZA - Sudafrica 1
Totale 3.781
Salva come PNG Salva come JPEG
Città #
Fairfield 406
Chandler 247
Ashburn 169
Rome 167
Woodbridge 154
Seattle 150
Houston 132
Cambridge 131
Dearborn 127
Wilmington 112
Singapore 87
Princeton 68
San Paolo di Civitate 59
Ann Arbor 51
Plano 48
Lawrence 45
Millbury 44
Beijing 42
San Diego 40
Helsinki 33
Milan 28
Sofia 27
Boston 26
New York 26
Andover 25
Vienna 25
Lomé 24
Dublin 18
Des Moines 15
Santa Clara 13
Southend 13
Toronto 13
Federal 10
Norwalk 10
Phoenix 8
Falls Church 7
Hefei 7
Jacksonville 7
San Mateo 7
Florence 6
Los Angeles 6
Mannheim 6
Nanjing 6
Redwood City 6
Brussels 5
Guangzhou 5
Monterotondo 5
Paris 5
Stockholm 5
Warsaw 5
Budapest 4
Dallas 4
Frankfurt am Main 4
Frosinone 4
Kunming 4
Munich 4
Reggio Calabria 4
Zurich 4
Ancona 3
Buenos Aires 3
Edinburgh 3
Fremont 3
Montréal 3
Ottawa 3
Palermo 3
Silvi 3
Ariccia 2
Athens 2
Bangkok 2
Bari 2
Bern 2
Boardman 2
Bursa 2
Bühl 2
Carapelle 2
Centro 2
Chennai 2
Chicago 2
Cornaredo 2
Crotone 2
Delft 2
Gallatin 2
Genova 2
Grafing 2
Hangzhou 2
Indiana 2
Jinan 2
Manchester 2
Marrakesh 2
Mexico City 2
Modena 2
Nanchang 2
Nanning 2
Naples 2
Pisa 2
Pomezia 2
Quzhou 2
Ridder 2
Romainville 2
Saint-Fons 2
Totale 2.805
Salva come PNG Salva come JPEG
Nome #
Kidney expression of toll like receptors in lupus nephritis: quantification and clinicopathological correlations 126
Reduction of autophagy and increase in apoptosis correlates with a favorable clinical outcome in patients with rheumatoid arthritis treated with anti-TNF drugs 124
Alarmin HMGB1 and soluble RAGE as new tools to evaluate the risk stratification in patients with the antiphospholipid syndrome 108
Treating lupus patients with antimalarials. analysis of safety profile in a single-center cohort 96
Prevalence, sensitivity and specificity of antibodies against carbamylated proteins in a monocentric cohort of patients with rheumatoid arthritis and other autoimmune rheumatic diseases 96
Acute longitudinal myelitis following Cryptococcus laurentii pneumonia in a patient with systemic lupus erythematosus. 94
Antibodies to age-β2 glycoprotein I in patients with antiphospholipid antibody syndrome. 93
A monocentric cohort of obstetric seronegative anti-phospholipid syndrome 89
Evaluation of the Patient Acceptable Symptom State (PASS) in Italian Patients Affected by Systemic Lupus Erythematosus: Association with Disease Activity Indices 85
The chronic damage in systemic lupus erythematosus is driven by flares, glucocorticoids and antiphospholipid antibodies: Results from a monocentric cohort 85
Elevated Serum Level of HMGB1 in Patients with the Antiphospholipid Syndrome 82
Tissue factor over-expression in platelets of patients with anti-phospholipid syndrome: induction role of anti-β2-GPI antibodies 82
Association between Staphylococcus aureus nasal carriage and disease phenotype in patients affected by systemic lupus erythematosus 79
Mycophenolate mofetil in systemic lupus erythematosus: results from a retrospective study in a large monocentric cohort and review of the literature. 75
Anti-mutated citrullinated vimentin antibodies in antiphospholipid syndrome: diagnostic value and relationship with clinical features 75
Autoantibodies specific to D4GDI modulate Rho GTPase mediated cytoskeleton remodeling and induce autophagy in T lymphocytes. 73
Systemic Lupus Erythematosus with and without Anti-dsDNA Antibodies: Analysis from a Large Monocentric Cohort 73
Early response to apremilast treatment in psoriatic arthritis: a real-life ultrasonographic follow-up study 72
TNFα expressed on the surface of microparticles modulates endothelial cell fate in rheumatoid arthritis 71
Microparticles and autophagy, a new frontier in the understanding of atherosclerosis in rheumatoid arthritis 71
Effectiveness and safety of baricitinib in rheumatoid arthritis. a monocentric, longitudinal, real-life experience 71
Validation of a disease-specific health-related quality of life measure in adult Italian patients with systemic lupus erythematosus: LupusQoL-IT. 69
Pregnancy outcome in systemic lupus erythematosus patients. a monocentric cohort analysis 69
The Role of Posttranslational Protein Modifications in Rheumatological Diseases: Focus on Rheumatoid Arthritis 68
OP0204 LUPUS COMPREHENSIVE DISEASE CONTROL IN SYSTEMIC LUPUS ERYTHEMATOSUS PATIENTS: APPLICATION OF A NEW INDEX 67
The Role of Disease Activity Score 28 in the Evaluation of Articular Involvement in Systemic Lupus Erythematosus. 66
Malignant cerebral infarction after ChAdOx1 nCov-19 vaccination: a catastrophic variant of vaccine-induced immune thrombotic thrombocytopenia 66
Comprehensive disease control in systemic lupus erythematosus 65
Rituximab infusion-related adverse event rates are lower in patients with systemic lupus erythematosus than in those with rheumatoid arthritis. 62
The mosaic of "seronegative" antiphospholipid syndrome. 62
Diagnosis of catastrophic anti-phospholipid syndrome in a patient tested negative for conventional tests 58
Flare, Persistently Active Disease, and Serologically Active Clinically Quiescent Disease in Systemic Lupus Erythematosus: A 2-Year Follow-Up Study 58
Musculoskeletal ultrasound in monitoring response to apremilast in psoriatic arthritis patients: results from a longitudinal study 58
Ultrasound evaluation of hand, wrist and foot joint synovitis in systemic lupus erythematosus. 57
Anti-vimentin/cardiolipin IgA in the antiphospholipid syndrome: a new tool for “seronegative” diagnosis 55
“Non-criteria antiphospholipid antibodies”: bridging the gap between seropositive and seronegative Antiphospholipid Syndrome 54
Five-years drug survival of mycophenolate mofetil therapy in patients with systemic lupus erythematosus. comparison between renal and non-renal involvement 54
Premature ovarian failure in patients affected by systemic lupus erythematosus. a cross-sectional study 53
Janus kinases inhibitors for treating patients with rhupus 53
T lymphocytes from patients with systemic lupus erythematosus are resistant to induction of autophagy 52
High Prevalence of Antinuclear Antibodies in Children with Thyroid Autoimmunity 51
Autoantibodies specific to a peptide of β2-glycoprotein I cross-react with TLR4, inducing a proinflammatory phenotype in endothelial cells and monocytes. 50
Switching between TNFα antagonists in rheumatoid arthritis: Personal experience and review of the literature 49
Carbamylation of β2-GPI generates new autoantigens for antiphospholipid syndrome. a new tool for diagnosis of "seronegative" patients 49
The role of osteopontin as a candidate biomarker of renal involvement in systemic lupus erythematosus. 48
Jaccoud's arthropathy in systemic lupus erythematosus: clinical, laboratory and ultrasonographic features 43
Hydroxychloroquine cardiotoxicity: a case-control study comparing patients with COVID-19 and patients with systemic lupus erythematosus 43
Relationship between gender differences and clinical outcome in patients with the antiphospholipid syndrome 42
STUDIO PROSPETTICO MONOCENTRICO PER LA VALUTAZIONE DELLO STATO DI SALUTE MEDIANTE ‘‘PATIENT ACCEPTABLE SYMPTOM STATE’’ (PASS) IN PAZIENTI AFFETTI DA LUPUS ERITEMATOSO SISTEMICO: CORRELAZIONE GLI INDICI DI ATTIVITÀ DI MALATTIA 42
A COMPLETE REMISSION LASTING AT LEAST ONE YEAR INFLUENCES THE OUTCOME IN PATIENTS AFFECTED BY SLE: RESULTS FROM A LARGE MONOCENTRIC COHORT 39
Lung ultrasound compared to computed tomography detection and automated quantification of systemic sclerosis-associated interstitial lung disease: preliminary study 35
Joint involvement influences quality of life in systemic lupus erythematosus patients 35
The role of musculoskeletal ultrasound in predicting the response to JAK inhibitors. results from a monocentric cohort 35
PREVALENZA DELLO STAFILOCOCCO AUREO NASALE IN PAZIENTI AFFETTI DA LUPUS ERITEMATOSO SISTEMICO 33
AUTOANTIBODIES SPECIFIC TO ESTROGEN RECEPTOR α PLAY A POTENTIAL ROLE IN THE PATHOGENESIS OF SYSTEMIC LUPUS ERYTHEMATOSUS INTERFERING WITH T LYMPHOCYTE HOMEOSTASIS 32
Outcome in patients with rheumatoid arthritis switching TNF-alpha antagonists: a single center, observational study over an 8-year period 32
CORRELAZIONE FRA CLASSE ISTOLOGICA E INDICE DI ESISTENZA RENALE NEI PAZIENTI CON NEFRITE LUPICA 31
COMPARSA DI REPLICAZIONE VIRALE DURANTE IL TRATTAMENTO CON CYA IN PAZIENTECON ARTRITE REUMATOIDE E POSITIVITÀ PER ANTICORPI ANTI-HCV. 29
VALUTAZIONE DEL COINVOLGIMENTO DELLE ARTICOLAZIONI METATARSOFALANGEE IN PAZIENTI AFFETTI DA LUPUS ERITEMATOSO SISTEMICO: UNO STUDIO ULTRASONOGRAFICO 28
Development of systemic autoimmune diseases in healthy subjects persistently positive for antiphospholipid antibodies. long-term follow-up study 28
Low incidence of flares, pesistently active disease (PAD) in a cohort of Italian patients with systemic lupus erhytemathosus. 2-years follow-up 25
Multicentre case-control study evaluating the safety of anti-SARS-CoV-2 vaccines in a cohort of patients with systemic vasculitis 24
Passaggio ad un secondo anti-TNFα in pazienti con artrite reumatoide (AR): studio osservazionale, longitudinale della durata di 8 anni in una coorte di 692 pazienti. 24
Low preconception complement levels are associated with adverse pregnancy outcomes in a multicenter study of 260 pregnancies in 197 women with antiphospholipid syndrome or carriers of antiphospholipid antibodies 23
null 22
null 20
EVALUATION OF THE PATIENT ACCEPTABLE SYMPTOM STATE (PASS) IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS: ASSOCIATION WITH DISEASE ACTIVITY INDICES. 19
RENAL RESISTIVE INDEX IN LUPUS NEPHRITIS: CORRELATION WITH RENAL FUNCTION AND ASSOCIATION WITH HISTOLOGICAL FEATURES. 18
Good safety profile of repeated B cell depletion therapy in patients with refractory systemic lupus erythematosus. 18
null 17
Increased eryptosis in patients with primary antiphospholipid syndrome (APS): a new actor in the pathogenesis of APS 13
Does seronegative obstetric APS exist. “pro” and “cons” 10
DEFICIT NELL’AUTOFAGIA DEI LINFOCITI T DI PAZIENTI CON LUPUS ERITEMATOSO SISTEMICO: POTENZIALE RUOLO DEGLI AUTOANTICORPI ANTI-LINFOCITA 9
The role of musculoskeletal ultrasound in predicting the response to JAK inhibitors. results from a monocentric cohort 9
Tapering and discontinuation of glucocorticoids in patients with rheumatoid arthritis treated with tofacitinib. 8
UN SOTTOGRUPPO DI ANTICORPI ANTI-BETA2 GLICOPROTEINA I CROSS-REAGISCE CON IL TOLL-LIKE RECEPTOR 4 INDUCENDO UN FENOTIPO PROINFIAMMATORIO NELLE CELLULE ENDOTELIALI E NEI MONOCITI 3
Totale 4.002
Salva come PNG Salva come JPEG
Categoria #
all - tutte 14.092
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 14.092
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020644 0 0 8 24 76 155 127 81 75 49 39 10
2020/2021400 26 63 15 8 12 12 4 35 58 86 41 40
2021/2022825 25 43 69 70 104 41 6 73 50 65 139 140
2022/2023900 133 205 56 92 93 106 3 69 65 15 45 18
2023/2024507 35 64 42 26 34 60 38 41 10 59 57 41
2024/2025136 32 50 54 0 0 0 0 0 0 0 0 0
Totale 4.002